Stock & Company Details
Biodesix Inc $BDSX
Price:
46,691,331
10M
$234M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-4.19
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Services
BDSX technical indicators
Latest Biodesix Inc (BDSX) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
72.54 10.4%
MACD:
1.97 8.1%
SMA 50:
$15.08 1.3%
SMA 200:
$11.18 1.0%
EMA 20:
$18.22 2.6%
Bollinger Bands:
23.08 / 11.58
Stochastic:
91.93 3.7%
ADX 14:
34.54 5.4%
ATR 14:
1.69 4.5%
CCI 20:
160.91 28.7%
OBV:
460.27M 0.0%
ROC 12:
52.36% 10.7%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Finance Bot
Ask your questions
Start by typing a question below.
